You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
廣生堂(300436.SZ)漲停 公司兩款創新藥可能對mRNA新冠病毒有效
格隆匯 02-11 09:44
格隆匯2月11日丨廣生堂(300436.SZ)漲停,報38.18元,暫成交5970萬元,漲停封單超2萬手,最新總市值53.45億元。

公司昨日盤後公告,2020年2月6日,公司向疫情核心區華中科技大學同濟醫學院附屬協和醫院遞交了研究者發起的G2、G3兩個仿製藥用於治療新型冠狀病毒肺炎臨牀研究的全套倫理審批資料。2020年2月7日,研究者發起的臨牀“G2或G3仿製藥治療輕、中度新型冠狀病毒感染的肺炎的小樣本預試驗研究”獲得倫理批件,現正在有序推進中。公司抗病毒全球創新藥GST-HG131、GST-HG121已開發研究五年,特異性針對乙肝病毒的mRNA,分析認為可能對其他病毒有效,包括同樣擁有的mRNA的新型冠狀病毒。在國內知名臨牀專家的指導下,GST-HG131、GST-HG121等創新藥現已在浙江大學附屬第一醫院P3實驗室開展抗新型冠狀病毒體外細胞活性測試中。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account